Results 271 to 280 of about 54,431 (288)

Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial

Annals of Oncology, 2019
Chigusa Morizane, J Mizusawa, N Okano
exaly  

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Lancet, The, 2019
Harry Heijerman, Edward F Mckone, Damian G Downey   +2 more
exaly  

Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041)

Annals of Oncology, 2011
Daisuke Aoki, F Takahashi, Noriyuki Katsumata   +2 more
exaly  

Ocena kliniczna uszczelniacza AH Plus

Magazyn Stomatologiczny, 1998
Luciński, Rafał, Szczepankiewicz, Włodzimierz   +1 more
openaire  

Anxiety, defence and the elevated plus-maze

Neuroscience and Biobehavioral Reviews, 1997
R J Rodgers
exaly  

Fourth-Generation QuantiFERON-TB Gold Plus: What Is the Evidence?

Journal of Clinical Microbiology, 2020
Catherine A Hogan, Madhukar Pai, Niaz Banaei   +2 more
exaly  

CEPHALOTHIN PLUS AN AMINOGLYCOSIDE IS MORE NEPHROTOXIC THAN METHICILLIN PLUS AN AMINOGLYCOSIDE

Lancet, The, 1978
Jerrold J Ellner, J J Lipsky
exaly  

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

Lancet, The, 2014
Edward B Garon, Tudor-Eliade Ciuleanu, OSCAR Arrieta   +2 more
exaly  

First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus

Journal of Infection, 2016
Elisa Petruccioli, TERESA Chiacchio, Ilaria Pepponi   +2 more
exaly  

Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial

Lancet, The, 2016
Nicolino Ruperto, Angela Pistorio, Sheila Oliveira   +2 more
exaly